File:Role of diet and its effects on the gut microbiome in the pathophysiology of mental disorders.pdf

From Wikimedia Commons, the free media repository
Jump to navigation Jump to search
Go to page
next page →
next page →
next page →

Original file(1,239 × 1,645 pixels, file size: 1,019 KB, MIME type: application/pdf, 13 pages)

Captions

Captions

Role of diet and its effects on the gut microbiome in the pathophysiology of mental disorders

Summary[edit]

Description
English: There is emerging evidence that diet has a major modulatory influence on brain-gut-microbiome (BGM) interactions with important implications for brain health, and for several brain disorders. The BGM system is made up of neuroendocrine, neural, and immune communication channels which establish a network of bidirectional interactions between the brain, the gut and its microbiome. Diet not only plays a crucial role in shaping the gut microbiome, but it can modulate structure and function of the brain through these communication channels. In this review, we summarize the evidence available from preclinical and clinical studies on the influence of dietary habits and interventions on a selected group of psychiatric and neurologic disorders including depression, cognitive decline, Parkinson’s disease, autism spectrum disorder and epilepsy. We will particularly address the role of diet-induced microbiome changes which have been implicated in these effects, and some of which are shared between different brain disorders. While the majority of these findings have been demonstrated in preclinical and in cross-sectional, epidemiological studies, to date there is insufficient evidence from mechanistic human studies to make conclusions about causality between a specific diet and microbially mediated brain function. Many of the dietary benefits on microbiome and brain health have been attributed to anti-inflammatory effects mediated by the microbial metabolites of dietary fiber and polyphenols. The new attention given to dietary factors in brain disorders has the potential to improve treatment outcomes with currently available pharmacological and non-pharmacological therapies.
Date
Source https://www.nature.com/articles/s41398-022-01922-0
Author J. Horn, D. E. Mayer, S. Chen, and E. A. Mayer

doi:10.1038/s41398-022-01922-0

Licensing[edit]

w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 4.0 International license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current03:23, 26 July 2022Thumbnail for version as of 03:23, 26 July 20221,239 × 1,645, 13 pages (1,019 KB)Koavf (talk | contribs)Uploaded a work by J. Horn, D. E. Mayer, S. Chen, and E. A. Mayer from https://www.nature.com/articles/s41398-022-01922-0 with UploadWizard

The following page uses this file:

Metadata